Citi analyst Joanne Wuensch raised the firm’s price target on Johnson & Johnson to $250 from $232 and keeps a Buy rating on the shares. The firm says the company reported good Q4 results with “beat and raise” potential in 2026.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Johnson & Johnson price target raised to $240 from $230 at Wells Fargo
- Johnson & Johnson: Solid Fundamentals but Fully Valued with Litigation Overhang Supporting Hold Rating
- Johnson & Johnson Projects Strong Growth Beyond STELARA
- Midday Fly By: Netflix reports Q4 beat, Smithfield to acquire Nathan’s
- Johnson & Johnson says ‘very confident’ in 2026 outlook